Treat Stroke to Target trial results favour intensive LDL lowering.
Findings affirm phase 3 trial results.
DAPA offers a new approach to treating HFrEF in patients regardless of T2D.
Luc studied at the CHU Saint Antoine, at Tenon, Rothschild and Trousseau. He first became interested in pulmonology when working in a military hospital burns unit. He was later appointed Chief Resident at Necker Children's hospital, where he founded an Asthma School. In 1996, he opened his own paediatric pulmonology practice.